How SAIC’s Artemis II Mission Assurance Role Could Shape Science Applications International (SAIC) Investors’ Outlook

• Earlier this month, Science Applications International Corp. announced its role as NASA’s mission assurance partner for the completed Artemis II lunar mission, providing safety analysis, risk mitigation tools, and real-time oversight across the Space Launch System, Orion spacecraft, ground systems, and crew survival over the nearly 10‑day journey.
• The company’s deep integration into Artemis II, from cross-program hazard analysis to post‑flight lessons learned, highlights its embedded position in complex space and defense programs where mission safety is central.
• Next, we’ll examine how SAIC’s mission assurance work on Artemis II could influence its investment narrative centered on government technology modernization.

The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Science Applications International Investment Narrative Recap

To own SAIC, you need to believe that its core role in complex, mission critical government programs can offset slow top line growth and budget uncertainty. The Artemis II mission assurance work reinforces SAIC’s relevance in high value space and defense contracts, but does not fundamentally change the near term catalyst, which is improving margins through automation, nor the biggest risk, which remains contract and funding delays from a pressured federal budget.

Among recent developments, the addition of Paul Eremenko and Admiral Michael Rogers to the board stands out alongside Artemis II. Their backgrounds in AI, aerospace, and cyber defense intersect directly with SAIC’s push into higher margin digital modernization and mission integration, potentially affecting how the company balances growth opportunities against pricing pressure, rising competition, and the ongoing shift toward more outcome based government contracts.

Yet against this promising backdrop, investors should still pay close attention to how prolonged federal budget uncertainty could...

Read the full narrative on Science Applications International (it's free!)

Science Applications International's narrative projects $7.7 billion revenue and $344.8 million earnings by 2028. This requires 1.0% yearly revenue growth and a $54.2 million earnings decrease from $399.0 million today.

Uncover how Science Applications International's forecasts yield a $113.38 fair value, a 19% upside to its current price.

Exploring Other Perspectives

While consensus focuses on modest growth and budget risks, the most optimistic analysts assumed revenue near US$7.6 billion and earnings of about US$392 million before this news, suggesting a far more upbeat path than the caution implied by concerns over a slower internal shift to next generation digital and cloud solutions.

Explore 3 other fair value estimates on Science Applications International - why the stock might be worth just $113.38!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Science Applications International research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Science Applications International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Science Applications International's overall financial health at a glance.

Seeking Other Investments?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Invest in the nuclear renaissance through our list of 93 elite nuclear energy infrastructure plays powering the global AI revolution.
• AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 59 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com